Research at risk: after-school nutrition and career readiness for NYC middle-schoolers

Funding has been cut short for a national program to help young people feed themselves and their families nutritiously.

Fei Wang named senior faculty fellow in clinical AI at Cornell Tech

Wang's newly established role will strengthen Cornell Tech’s leadership in digital health and artificial intelligence, while also expanding interdisciplinary collaboration between Cornell Tech and Weill Cornell Medicine.

Around Cornell

Immune tolerance to gut microbes is initiated by a key bacterial sensor

Weill Cornell Medicine investigators have found that an immune “tolerance” to gut microbes depends on an ancient bacterial-sensing protein that is normally considered a trigger for inflammation.

Research at risk: Stopping metastatic cancer

Weill Cornell Medicine researcher Nancy Du received a $500,000 grant from the Congressionally Directed Medical Research Programs at the U.S. Department of Defense, but a stop-work order brought her research to a halt in April.

Faculty-led startup is using AI to reimagine software reliability

Cornell Tech Assistant Professor Raaz Dwivedi has co-founded Traversal, a startup emerging from stealth this week with a mission: to transform how modern software systems detect and resolve outages using artificial intelligence.

Around Cornell

Inside the medical crash cart robot: Designing for urgency, collaboration, and clarity

Cornell Tech researchers unveiled a robot that helps emergency room teams locate life-saving supplies faster, revealing how design can shape collaboration under pressure.

Around Cornell

VitalHide puts privacy first in the age of wireless health monitoring

 A new Cornell Tech system blocks unwanted surveillance of your vital signs, while still enabling trusted care.

Around Cornell

Study provides new insights into genetic complexity of metastasis

Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center provide fresh insights about how cancers evolve when they metastasize – insights that could aid in developing strategies to improve the effectiveness of treatment.

Treatment switch, liquid biopsy improve breast cancer outcomes

A clinical trial in patients with advanced breast cancer has found the use of liquid biopsy blood tests for early detection of a treatment-resistant mutation, followed by a new type of treatment, substantially extends the period of tumor control.